Dynamics of Arterial Wall Transport for Small Hydrophobic Drugs

Abstract : Drugs used in drug-eluting stents (DES) to inhibit proliferation of smooth muscle cells (SMCs) also limit re-endothelialization at the site of stent implantation [1]. Thus, treated patients face an increased risk of late-stent thrombosis. Avoiding this adverse side effect represents one of the major challenges in the design of next-generation DES.
Document type :
Conference papers
Complete list of metadatas

https://hal-polytechnique.archives-ouvertes.fr/hal-01025967
Contributor : Denis Roura <>
Submitted on : Tuesday, July 22, 2014 - 1:02:13 PM
Last modification on : Wednesday, March 27, 2019 - 4:39:25 PM

Identifiers

Collections

Citation

Franz Bozsak, Jean-Marc Chomaz, Abdul I. Barakat. Dynamics of Arterial Wall Transport for Small Hydrophobic Drugs. 2012 Summer Bioengineering Conference, Jun 2012, Fajardo, Puerto Rico, United States. pp.565-566, ⟨10.1115/SBC2012-80541⟩. ⟨hal-01025967⟩

Share

Metrics

Record views

167